Hensley Mark Earl

Heron Therapeutics, Inc. · Chief Operating Officer

Hensley Mark Earl is listed in public filings as officer: Chief Operating Officer. This Hensley Mark Earl insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Heron Therapeutics, Inc. (HRTX). Investors use Hensley Mark Earl's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Heron Therapeutics, Inc.HRTX--136.8k sharesGrant / ExerciseMay 6, 2026Disclosure amount unavailable125k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Heron Therapeutics, Inc.HRTX--11.8k sharesGrant / ExerciseApr 30, 2026Disclosure amount unavailable11.8k shares----
Heron Therapeutics, Inc.HRTX--188.3k sharesGrant / ExerciseJan 30, 2026Disclosure amount unavailable188.3k shares----
Heron Therapeutics, Inc.HRTX--188.3k sharesGrant / ExerciseJan 30, 2026Disclosure amount unavailable188.3k shares----
Heron Therapeutics, Inc.HRTX--500k sharesGrant / ExerciseMay 6, 2025Disclosure amount unavailable500k shares----